IRCT20171112037409N1RecruitingPhase 3
Evaluation the effectiveness of Ziziphus spina-christi topical solution plus clindamycin 1% compared with Clindamycin1% plus placebo in mild to moderate acne
Conditions
Trial Snapshot
- Phase
- Phase 3
- Status
- Recruiting
- Enrollment
- 110
Study Overview
Brief Summary
No summary available.
Study Design
- Study Type
- Interventional
Eligibility Criteria
- Ages
- 15 years to 45 years (—)
- Sex
- All
Inclusion Criteria
- •Subjects in age of 15 to 45 years old
- •Chief complaint: mild to moderate Acne vulgaris
- •subject willingness of herbal topical medicines use
Exclusion Criteria
- •History of polycyctic ovary
- •use of acnegenic medications such as corticosteroid, hurmonal or anti-psychotic medications
- •mechanical acne and gram-negative folliculitis
- •History of dermal allergy
Investigators
Similar Trials
Recruiting
Phase 3
Evaluation of efficacy of Ziziphus Vulgaris formula to prevent drug induced liver enzyme disorder” in pulmonary tuberculosis PatientsIRCT20181107041586N1Sari University of Medical Sciences70
Completed
Phase 3
An herbal medication as complementary conventional chemotherapy for gastric and esophageal cancer patientsCondition 1: Oesophagus cancer. Condition 2: Gastric cancer.Malignant neoplasm of oesophagusMalignant neoplasm of stomachIRCT2016092529963N1Vice chancellor for research ,Digestive Diseases Research Institute, Tehran University of Medical Sc83
Completed
Phase 3
Evaluation of the efficacy of Spinal-Z on patients with gastrointestinal cancerIRCT201612051165N15Baqiyatallah University of Medical Sciences61
Not yet recruiting
Not Applicable
To study the role of Zinc combined with standard treatment for COVID-19CTRI/2020/07/026340Ramen Goel
Recruiting
Phase 3
Investigating the effect of Oral capsule of Ziziphora tenuior plant extract on Primary DysmenorrhoeaPrimary dysmenorrhea.IRCT20240506061675N1Shahid Beheshti University of Medical Sciences94
